Cargando…
A double-blind placebo-controlled trial of minocycline on translocator protein distribution volume in treatment-resistant major depressive disorder
Gliosis is implicated in the pathophysiology of many neuropsychiatric diseases, including treatment-resistant major depressive disorder (TRD). Translocator protein total distribution volume (TSPO V(T)), a brain marker mainly reflective of gliosis in disease, can be measured using positron emission t...
Autores principales: | Attwells, Sophia, Setiawan, Elaine, Rusjan, Pablo M., Xu, Cynthia, Kish, Stephen J., Vasdev, Neil, Houle, Sylvain, Santhirakumar, Apitharani, Meyer, Jeffrey H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164633/ https://www.ncbi.nlm.nih.gov/pubmed/34052828 http://dx.doi.org/10.1038/s41398-021-01450-3 |
Ejemplares similares
-
Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial
por: Dean, Olivia May, et al.
Publicado: (2014) -
Image Derived Input Function for [(18)F]-FEPPA: Application to Quantify Translocator Protein (18 kDa) in the Human Brain
por: Mabrouk, Rostom, et al.
Publicado: (2014) -
Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography study
por: Sacher, Julia, et al.
Publicado: (2012) -
Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial
por: Savitz, Jonathan B., et al.
Publicado: (2018) -
Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
por: Husain, Muhammad Ishrat, et al.
Publicado: (2020)